sodium reabsorption; arachidonic acid; cyclooxygenase; A6 cells; cytosolic phospholipase A 2 TRANSPORT OF SODIUM ACROSS principal cells in the distal collecting duct of the kidney is via an apical amiloridesensitive epithelial Na ϩ channel (ENaC) and a coupled basolateral Na ϩ -K ϩ -ATPase. This system vectorially moves Na ϩ from the external environment to the organism's internal environment. The rate-limiting step for this process is by regulation of ENaC. The principal means of regulating Na ϩ transport in the cortical collecting duct is hormonal via the mineralocorticoid, aldosterone, and the peptide, antidiuretic hormone (19, 21, 40) . Both hormones increase the apical membrane conductance to Na ϩ , thereby promoting Na ϩ reabsorption. Much effort has been focused on understanding the cellular mechanism of these hormonal regulatory events; however, the intracellular mechanism(s) responsible for their effects are not well identified. Less well described are the mechanisms of fine-tuning and local, intratubular, or cellular control of Na ϩ uptake. Phospholipase A 2 , arachidonic acid, and ion channels. The phospholipases A 2 (PLA 2 ) are a family of enzymes that metabolize membrane phospholipids and are generally classified into three groups, secretory (sPLA 2 ), Ca 2ϩ independent, and cytosolic PLA 2 (cPLA 2 ) (33) . Although the latter was originally termed cytosolic because it is found in the cytosol, this term is somewhat misleading because the active form of cPLA 2 is membrane associated. cPLA 2 has long been recognized to play an important role in a number of cellular processes. cPLA 2 hydrolyzes the sn-2 position of phospholipids, resulting in the release of free fatty acids, primarily arachidonic acid (AA) in eukaryotic cells, and lysophospholipids. Both the free fatty acids and the lysophospholipids then may themselves mediate a number of responses by both intracellular and extracellular signaling. It is also well documented that a variety of plasma membrane receptors act on PLA 2 (5, 33) . Upon release, AA may initiate signaling or can be metabolized into a wide range of signaling factors by cyclooxygenases, lipoxygenases, and cytochrome P-450 monooxygenases, producing a cascade of prostaglandins, leukotrienes, and monooxygenase products, respectively. Determined by the predominate active metabolic pathways, the release of AA produces a prodigiously diverse range of physiological and pathological effects. In particular, many ion channels are affected by either AA itself and/or the various metabolites of AA (31) . Free unsaturated fatty acids, principally AA, have varying effects on ion channels, thus a priori, the effects of AA on a given ion channel cannot be guessed. The effects of AA can either be inhibitory (23) or stimulatory (11, 13, 39) . In addition, many studies involving the addition of free AA, usually at concentrations exceeding normal physiological levels, may not adequately address the physiological role of AA or its metabolites on ion transport.
In the 1970s, it was suggested that Na ϩ reabsorption in the toad bladder was associated with an increased turnover of phospholipids (22) , most likely through the involvement of PLA (42) . To determine the possible effects of phospholipid turnover, and, in particular, AA on amiloride-sensitive Na ϩ channels and transepithelial Na ϩ reabsorption, we chose to manipulate free AA levels by altering cPLA 2 activity, using aristolochic acid as a relatively selective inhibitor of cytosolic PLA 2 , a strategy that had proved effective in previous work involving the maxi-K ϩ channel in GH 3 cells (13, 14) . This paper demonstrates that cPLA 2 is tonically active in transporting A6 cells and that this activity is necessary for the support of transepithelial transport. Interestingly, AA is shown to reduce Na ϩ transport, whereas the metabolic product of AA, prostaglandin E 2 (PGE 2 ), is found to be necessary to maintain normal transport. Furthermore, the sidedness of cPLA 2 inhibition suggests there is a local apical membrane-associated pool of cPLA 2 at or near the apical Na ϩ channel in addition to the perinuclear and endoplasmic reticular localization of cPLA 2 .
MATERIALS AND METHODS
Cell culture. The 2F3 clonal line of A6 cells or A6 cells were grown on permeable supports under conditions that have been demonstrated to produce transepithelial Na ϩ transport, as well as a predominance of the low-conductance highly selective amiloride-sensitive Na ϩ channel in the apical membrane (21) . Open-circuit current measurements were made using the 2F3 clonal cell line (which, in general, produces more current than the A6 cell line). Short-circuit current and single channel measurements were made using the A6 cell line. It should be noted that A6 cells were found to respond identically to the 2F3 cell line in open-circuit current measurements, albeit with a lower magnitude of current. Cells were maintained at 26°C in 4% CO 2 in a mixture of 7:3 Coon's F-12 and Leibovitz's L-15 with 25 mM NaHCO 3 (pH 7.4), 10% fetal calf serum, 1% streptomycin, and 0.6% penicillin. Cells for transepithelial current measurements and assays involving free AA production or cPLA 2 activity were grown on 25-mm Anapore supports (Nunc). Cells for patch-clamp analysis were plated on rat tail collagen-coated Millipore-CM filters attached to the bottom of custom-made Lucite rings. Cells on both types of permeable supports were grown to confluency in the above conditions in the presence of 1.5 M aldosterone. Under these conditions, high-resistance monolayers formed within 7-14 days. Short-circuit current measurements were performed on A6 cells grown under the conditions reported by Blazer-Yost et al. (4) .
Measurement of transepithelial current. The quality of high-resistance monolayer formation was monitored using an epithelial voltohmmeter (EVOM; World Precision Instruments). This instrument consists of a pair of Ag-AgCl electrodes mounted in "chopstick" fashion attached to a customized voltohmmeter. Both transepithelial potential (in mV) and transepithelial resistance (in K⍀) were measured with this instrument. Transepithelial current was calculated by Ohm's law, expressed as A/cm 2 , and is referred to as opencircuit current in the text to clearly distinguish it from the short-circuit currents measured in Ussing chambers. Although the open-circuit current technique tends to underestimate the amount of current that would be obtained in short-circuit current measurements, EVOM measurements proved consistent and reliable for detecting changes in transepithelial voltage, resistance, and current. Because cells used in EVOM measurements were at room temperature and not aerated with 95:5 gas, current tended to slowly decline with time (see Figs. 1A and 7A). Experiments were performed in serum-free A6 culture media. Upon replacement of serumcontaining media with serum-free media, currents typically become relatively stable within 5 min. To corroborate opencircuit current measurements, conventional short-circuit current measurements were performed. A6 cells were grown to confluency on Transwell supports, and the supporting membrane was then placed in an Ussing chamber for measurement of short-circuit current as described by Blazer-Yost et al. (3) . Current from individual monolayers was allowed to stabilize (ϳ1-2 h) before drug addition. Data were recorded on a strip chart recorder, and current magnitudes were subsequently measured for plotting. No qualitative difference was observed between the methods of measurement or the cell line used (2F3 vs. A6).
AA ]AA was incorporated into the cellular lipids. Cells were then washed four times in PBS, and the efflux of labeled AA was monitored by a standard sample-and-replace method using fatty acid-free BSA in the efflux media to act as a trap for liberated free fatty acid. Samples were placed in scintillation cocktail (BioSafe II; Amersham), and radioactive decay was counted using a Packard 1900A scintillation counter. At the end of the sample period, cells were lysed in 0.1 N NaOH, and the cell lysate was counted to determine the counts remaining in the cells. Data were plotted as the percent counts remaining in the cells for each time point, and the slope of the relation was used to determine the relative rate of free AA release. This technique offers an advantage over PLA 2 activity measurements in cell lysates in that efflux (AA release) can be monitored on the apical side of the monolayer, thus providing a more accurate assessment of the free AA at the apical membrane.
Single channel patch-clamp recording. Cell-attached single channel patch data of ENaC were obtained as previously described by Kemendy et al. (25) and Ma and Ling (29) . Briefly, A6 cells were cultured on custom Lucite rings and viewed under Hoffman modulation optics mounted on a Nikon Diaphot inverted microscope. Patch pipettes with a tip resistance of 7-9 M⍀ were fabricated from TW150 glass on a Narishige PP-83 puller and fire-polished with a Narishige MF-83 polisher. Bath and pipette solutions contained (in mM): 96 NaCl, 3.4 KCl, 0.8 CaCl 2 , 0.8 MgCl 2 , and 10 HEPES at pH 7.4 (titrated with 1 N NaOH). Single channel currents from apical membrane patches were recorded with an Axon 1D amplifier and data digitized to a computer using a TL-1 data interface. Single channel data analysis was accomplished using pCLAMP software (Axon).
Reagents. [ 3 H]AA was obtained from Amersham. Aristolochic acid, ibuprofen, 5,8,11,14-eicosatetraynoic acid (ETYA), 7,7-dimethyleicosadienoic acid (DEDA), and PGE 2 were obtained from Biomol. All other reagents were obtained from either GIBCO BRL or Sigma.
Significance tests. Data are presented as means Ϯ SE. Significance was estimated using the Student's t-test with P Ͻ 0.05 indicating a significant difference.
RESULTS
Inhibition of cPLA 2 by application of the cPLA 2 inhibitor, aristolochic acid, produced opposite effects depending on whether application was to the apical or basolateral side of the transporting epithelial monolayer. We show (below) that inhibition of cPLA 2 from the apical side produces an increase in transepithelial current, whereas inhibition from the basolateral side produces an inhibition of transepithelial current. The apical effect is due to the downmodulation of apical Na ϩ channels (ENaC) by free AA produced by cPLA 2 activity. Current inhibition after inhibition of cPLA 2 from the basolateral side results predominately from an inhibition of PGE 2 production within the cells. It is important to note that both results imply that cPLA 2 is present and active in the aldosterone-stimulated monolayers and that disruption of cPLA 2 activity has significant effects on the magnitude of transepithelial Na ϩ transport. Inhibition of cPLA 2 from the apical side. The results of cPLA 2 inhibition after apical application of aristolochic acid is shown in Fig. 1 . Open-circuit transepithelial current shows a marked increase on application of aristolochic acid to the apical surface. Current was 6.8 Ϯ 0.2 A/cm 2 in the control monolayers and 7.5 Ϯ 0.3 A/cm 2 in the treated group at time zero. With the addition of an apical media containing 200 M aristolochic acid, current increased significantly within 1 min to 13.6 Ϯ 0.6 A/cm 2 (P Ͻ 0.001; Fig. 1A ). Addition of replacement apical media to the control group resulted in no significant change in current. Currents remained elevated approximately twofold for at least 5 min, with control and aristolochic acid-treated groups having currents of 5.6 Ϯ 0.2 and 13.6 Ϯ 0.5 A/cm 2 , respectively. Apical aristolochic acid reduced transepithelial resistance from 1.22 Ϯ 0.09 K⍀ in control to 0.95 Ϯ 0.06 K⍀. The increase in current with apical aristolochic acid was fully reversible, as shown in Fig.  1B . Open-circuit transepithelial current was 5.9 Ϯ 0.2 A/cm 2 before the apical addition of aristolochic acid. Apical aristolochic acid produced an increase in current to 9.6 Ϯ 0.3 A/cm 2 . Upon washout of apical aristolochic acid, currents were not significantly different from control, 5.9 Ϯ 0.3 A/cm 2 . All current was amiloride sensitive (data not shown).
In an effort to more fully describe the nature of current stimulation seen in the open-circuit current measurements with apical application of aristolochic acid, the short-circuit current method was applied. Identical results to those obtained in open-circuit conditions were observed upon apical application of 200 M aristolochic acid under short-circuit conditions ( Ϫ5 M amiloride to the apical bathing media reduced current in both the control and the aristolochic acid-treated groups, with current being 3.3 Ϯ 1.1 and 3.5 Ϯ 1.3 A/cm 2 , respectively. There was no significant difference in the amiloride-insensitive current component between each group.
Because there have been some reports that aristolochic acid can affect the activity of sPLA 2 (41), a specific inhibitor of sPLA 2 was applied to the apical side of transporting monolayers. , and addition of DEDA to the apical side did not significantly increase current; indeed, current was slightly decreased to 6.4 Ϯ 0.3 A/cm 2 . However, subsequent application of 100 M apical aristolochic acid produced a significant increase in transepithelial current (12.5 Ϯ 0.3 A/cm 2 , P Ͻ 0.001). Thus the apical aristolochic acid effect is not due to actions on sPLA 2 . Presumably, inhibition of cPLA 2 by apical aristolochic acid application should reduce the amount of free AA present at the apical membrane. One means of accessing the liberation of free AA is to measure the release (efflux) of labeled AA from the monolayers. Figure 4A shows the efflux of (Fig. 4B) . Efflux rates were 0.045 Ϯ 0.013 s Ϫ1 for the untreated group and 0.019 Ϯ 0.004 s Ϫ1 for monolayers treated with apical aristolochic acid (P Ͻ 0.05). It should be mentioned that the actual release of free AA is underestimated by monitoring the efflux of AA, because free AA will partition into the cellular membrane and the cytosol as well as the external media. Nonetheless, a decrease in AA release was observed, thus indicating that available free AA at the apical membrane is reduced by the apical application of aristolochic acid. No appreciable change in [ 3 H]AA efflux was detected with apical application of DEDA or with the basolateral application of aristolochic acid (data not shown).
The cPLA 2 liberation of free AA from the sn-2 position of membrane lipids results in the production of a lysophospholipid product. Either free AA or the lysophospholipid product may act as a signaling molecule, and, in addition, free AA is the substrate for a number of enzymes and can result in a prodigious number of different signaling molecules. In an effort to ascertain which signaling pathways are involved, an analog of AA containing four triple bonds (ETYA) vs. the four double bonds of AA can be employed. ETYA acts as an unsaturated free fatty acid as well as an inhibitor of the enzymes that normally metabolize free AA. It has thus been used to distinguish between free fatty acid effects and AA metabolic product effects. As shown in To determine whether the stimulation of transepithelial current observed with apical application of aristolochic acid in monolayers was due to a free fatty acid-induced reduction in ENaC activity, the patchclamp technique was employed. Figure 6 Inhibition of transepithelial open-circuit current by basolateral application of aristolochic acid was not 1 It is interesting to note that long-term (Ͼ15-20 min) application of aristolochic acid to the apical side also resulted in an inhibition of transepithelial current subsequent to current stimulation. The most likely explanation is that aristolochic acid is diffusing through or across the cell and reaching the sites that are more readily accessible from the basolateral membrane (the basolateral effect but with a lag time to the onset). All apical application experiments were performed with Ͻ10 min of aristolochic application to avoid this secondary effect. Transepithelial current increase was never observed subsequent to the decrease in current with basolateral aristolochic acid, thus suggesting a necessity for cPLA 2 activity in the support of transport. reversed by the basolateral application of ETYA. This differs from the effect of ETYA on the increase in current observed with apical application of aristolochic acid (see Fig. 5 ). Figure 7B shows the results when ETYA is added to the basolateral media subsequent to basolateral aristolochic acid application. Control opencircuit current was 3.8 Ϯ 0.2 A/cm 2 . Current was reduced to 1.8 Ϯ 0.1 A/cm 2 with a 10-min basolateral application of aristolochic acid. Subsequently, a 2-min application of basolateral ETYA (40 M) significantly reduced currents further to 1.0 Ϯ 0.06 A/cm 2 (P Ͻ 0.01). This indicates that the inhibition of current seen with basolateral application of aristolochic acid is not due to free fatty acid and implies that a metabolic product of AA may be involved in maintaining transepithelial transport. 2 The effect of basolateral application of aristolochic acid was also measured under short-circuit current conditions and is shown in Fig. 8 . The results did not differ from those observed in the open-circuit conditions (Fig. 7A) . Current began at 27 Ϯ 6 A/cm 2 for both control and experimental groups. Unlike the open-circuit current conditions, current level under short-circuit current was maintained throughout the experiment for the control group (26 Ϯ 6 A/cm 2 at 10 min). Addition of basolateral aristolochic acid (200 M) resulted in a marked decrease in short-circuit current, with a significant decrease clearly observed at 2 min (P Ͻ 0.05) and a large decrease observed at 10 min, 7 Ϯ 2 A/cm 2 with aristolochic acid vs. 26 Ϯ 6 A/cm 2 for the control group. Addition of 1 ϫ 10 Ϫ5 M amiloride reduced currents to similar levels of 4.2 Ϯ 0.9 and 4.1 Ϯ 0.9 A/cm 2 for control and experimental groups, respectively.
Perhaps the most probable AA metabolite to mediate support of transepithelial transport is the cyclooxygenase product of AA, PGE 2 . Chronic application of basolateral PGE 2 has been reported to increase Na ϩ channel number in the apical membrane of frog skin (17) and in A6 cells (27, 30) . If PGE 2 was necessary for transport, then inhibition of cPLA 2 might produce an inhibition of transport as observed in Figs. 7 and 8 , and the current inhibition should be prevented by the addition of exogenous PGE 2 to the basolateral side of the monolayer. Such experiments are summarized in Fig.  9 . Open-circuit current was measured under three conditions: basolateral aristolochic acid alone, basolateral PGE 2 alone, and simultaneous application of basolateral aristolochic acid and PGE 2 . Starting currents were 3.2 Ϯ 1.2 A/cm 2 for each group. As shown previously, basolateral application of aristolochic acid led to a 2 Experiments with basolateral ETYA alone also produced inhibition of current similar to basolateral aristolochic acid. This arises from ETYA inhibition of the enzymes that metabolize AA (i.e., cyclooxygenase). ETYA was used in this experiment as a means of distinguishing between a free fatty acid effect vs. an AA metabolite effect. (Fig. 9B) . Starting currents were 5.2 Ϯ 0.2 A/cm 2 for each group. Transepithelial current was reduced to 3.5 Ϯ 0.2 and 2.9 Ϯ 0.2 A/cm 2 with basolateral application of aristolochic acid or ibuprofen, respectively. Current reduction in both cases was reversed with basolateral addition of 10 M PGE 2 . Current 5 min after basolateral PGE 2 was 4.8 Ϯ 0.3 A/cm 2 in monolayers treated with basolateral aristolochic acid and 6.6 Ϯ 0.4 A/cm 2 for monolayers treated with basolateral ibuprofen. The difference in current magnitude after PGE 2 application is interesting and is addressed in DISCUSSION. Combined effect of cPLA 2 inhibition from the apical side and basolateral PGE 2 addition. The increase in transepithelial current observed with the apical application of aristolochic acid is additive, with the stimulation of current observed with the basolateral application of PGE 2 . Figure 10 shows transepithelial opencircuit current measurements from monolayers treated simultaneously with apical aristolochic acid (200 M) and basolateral PGE 2 (10 M). Starting current was 8.9 Ϯ 0.3 A/cm 2 . Combined application of apical aristolochic acid and basolateral PGE 2 resulted in a peak increase in current of 21.2 Ϯ 1.3 A/cm 2 at 10 min. Peak current magnitudes observed with apical application of aristolochic acid alone (Fig. 1A ) were 14.2 Ϯ 0.6 A/cm 2 , whereas those observed with basolateral PGE 2 were 6.7 Ϯ 0.5 A/cm 2 ( Fig. 9, A and B) . The sum of these current magnitudes, 20.9 A/cm 2 , is not significantly different from the 21.2 Ϯ 1.3 A/cm 2 observed in Fig. 10 .
DISCUSSION
The data presented demonstrate that cPLA 2 is tonically active in transporting A6 cells and that this activity is necessary for the support of transepithelial transport. Interestingly, however, a sidedness to cPLA 2 inhibition results in a divergent effect on transepithelial transport, with inhibition from the apical side resulting in an increase in current and inhibition from the basolateral side resulting in a decrease in current. The increase in transepithelial current observed with apical side inhibition of cPLA 2 results from Fig. 9 . Inhibition of open-circuit transepithelial current by basolateral application of aristolochic acid is prevented by basolateral application of prostaglandin E 2 (PGE 2 ). A: transepithelial current measured with basolateral application of aristolochic acid (at time 0, darker circles), basolateral PGE 2 (at time 0, triangles), or both aristolochic acid and PGE 2 (at time 0, lighter circles). Basolateral PGE 2 alone increased transepithelial current (P Ͻ 0.01) and was able to prevent the inhibition of current with basolateral application of aristolochic acid (P Ͻ 0.001, 15-min time point). For each group, n ϭ 6 2F3 monolayers. B: basolateral application of the cyclooxygenase inhibitor ibuprofen (at time 0, triangles) inhibits current to a similar degree as does basolateral application of aristolochic acid (at time 0, circles). Both effects are reversed by basolateral application of PGE 2 (arrow, at 5 min). For each group, n ϭ 6 2F3 monolayers. 1A ). Basolateral application of PGE 2 produced a current level of 6.7 Ϯ 0.5 A/cm 2 (see Fig. 9A ). In combination, current levels, as shown in this figure, peaked at 21.2 Ϯ 1.3 A/cm 2 (n ϭ 6 2F3 monolayers). The combined effect is not significantly different from the sum of the individual effects. the downmodulation of ENaC by free AA. The decrease in transepithelial current observed with basolateral side inhibition of cPLA 2 results in part from a decrease in the metabolic product of AA, PGE 2 . Furthermore, the sidedness of cPLA 2 inhibition suggests there is a local apical membrane-associated pool of cPLA 2 at or near the apical Na ϩ channel in addition to commonly found perinuclear and endoplasmic reticular localization of cPLA 2 . These data provide a novel and intriguing mechanism whereby transepithelial Na ϩ transport and thus fluid reabsorption can be modulated over a relatively rapid time course, as well as provide for differential modulation by apical or basolateral signaling mechanisms.
The apical effect. Free AA or free unsaturated fatty acids have been shown to affect a number of ion channels (31), producing either an increase (11, 12, 39) or a decrease (23) in single channel P o . The data presented herein not only demonstrates that free fatty acid reduces the P o of the apical Na ϩ channel, ENaC, but also shows that under normal conditions of transport (e.g., aldosterone stimulated), free AA is produced at the apical membrane and exerts a downmodulatory effect on ENaC, thus slowing transport. Inhibition of cPLA 2 , by aristolochic acid from the apical side of transporting A6 cell monolayers, produced an approximate twofold increase in transepithelial Na ϩ transport and a 58% decrease in the rate of AA liberated at the apical membrane. Apical ETYA reversed the stimulatory effect of apical aristolochic acid on transepithelial current, indicating that free AA itself was acting to downmodulate transport at the apical membrane. Although apical AA application produced similar results (not shown), these results were more variable and could be misleading due to cellular metabolism of AA into a variety of signaling molecules. ETYA provided an advantage in that it is an analog of AA and has similar effects on ion channels as AA (12); however, ETYA is not subject to cellular metabolism. Apical ETYA might also inhibit PGE 2 production, resulting in a reduction of current as with the basolateral effect of aristolochic acid or ibuprofen. However, if this were the principal means of the apical ETYA reduction of current, one would not expect current inhibition by AA or an additive effect of basolateral PGE 2 and apical aristolochic acid as is observed. In single channel recordings, ETYA reduced the P o of ENaC. The reduction in ENaC activity with ETYA supports the notion that tonic production of free AA at or near the apical membrane downmodulates ENaC activity and thus transepithelial transport of Na ϩ . The fact that an increase in transepithelial transport is observed with the inhibition of cPLA 2 from the apical side supports the presence of tonically active cPLA 2 at or near the apical Na ϩ channel in the transporting A6 cells. Alternatively, AA liberated at a locale distant to ENaC within the cell might be responsible for downmodulation of ENaC activity. This alternative hypothesis is less likely because inhibition of cPLA 2 by basolateral application of aristolochic acid does not produce the same affect as apical application.
The basolateral effect. Inhibition of cPLA 2 from the basolateral side of the A6 cell monolayer produced an effect on transepithelial current that was opposite from inhibition from the apical side. Basolateral application of aristolochic acid produced an inhibition of transepithelial current with a time course somewhat slower than that which was observed for the increase in current with apical aristolochic acid. Unlike that of the apical side effect, ETYA did not relieve the inhibition of current seen with basolateral side inhibition of cPLA 2 but rather led to a greater inhibition of current. This effect of ETYA is consistent with the notion that free AA is tonically produced within the cell and is being metabolized to products that act to support transepithelial transport. Basolateral addition of the cyclooxygenase product of AA metabolism, PGE 2 , was able to prevent as well as reverse the inhibitory effect of basolateral aristolochic acid application. In support of PGE 2 involvement, basolateral application of the cyclooxygenase inhibitor, ibuprofen, produced transepithelial current inhibition similar to that of aristolochic acid. The effect of ibuprofen was also reversed by the addition of PGE 2 . Interestingly, PGE 2 produced a more robust response subsequent to ibuprofen than subsequent to aristolochic acid. Inhibition of cPLA 2 would result in a decrease in all metabolic products of AA, whereas cyclooxygenase inhibition would only decrease prostaglandin production. Thus the more robust response with PGE 2 after ibuprofen may indicate the involvement of other AA metabolites involved in the support of transport. Indeed, the lipoxygenase product of AA, LTD 4 , has been shown to increase Na ϩ channel activity in A6 cells (8) .
The inhibitory effect on transport by basolateral side inhibition of cPLA 2 supports the notion that cPLA 2 within transporting A6 cells is active, and along with cyclooxygenase activity, is necessary to support Na ϩ transport. Indeed, basolateral PGE 2 has previously been shown to increase short-circuit current and Na ϩ conductance in A6 cells (27, 30) and frog skin (17) .
Model for the divergent effect. The divergent effect on transepithelial current with inhibition of cPLA 2 from the apical and basolateral sides suggests discrete intracellular pools of cPLA 2 . Although cPLA 2 has predominately been localized to the perinuclear and endoplasmic reticular membranes within cells (35) , several studies have reported evidence that suggests that cPLA 2 also can occur at the plasma membrane in confluent bovine endothelial cells (36) , in fibroblasts (7), in glomerular epithelial cells (28) , and in bradykinin-stimulated Madin-Darby canine kidney cells (26) . Perhaps the most convincing evidence for cPLA 2 presence in the plasma membrane derives from inside-out patch-clamp experiments in GH 3 cells, where functionally, cPLA 2 occurs in the same membrane patch as the Ca 2ϩ -activated K ϩ channel (BK channel) (14) . Ion channels occur in the plasma membrane at relatively low abundance. At minimum, if one cPLA 2 was associated with one BK channel, one might expect the plasma membrane abundance of cPLA 2 to also be rel-atively low, particularly compared with the nuclear envelope.
A receptor-coupled apical membrane-situated cPLA 2 could act as the transduction mechanism for intraluminal signaling molecules. Ϫ secretion, and Na ϩ reabsorption, where it is speculated that external ATP, somehow dependent on active cystic fibrosis transmembrane conductance regulator (CFTR) Cl Ϫ channel, acts to inhibit Na ϩ reabsorption and the Na ϩ channel (15). Endothelin-1 has also been shown to increase free AA levels (24) in smooth muscle and to affect Na ϩ transport in epithelia (20) . The emerging precedence from these data suggests that receptor-mediated signaling through cPLA 2 and AA release can have an effect on ion transport processes. Receptors to adenosine, ATP, and endothelin-1 have been identified in renal collecting duct epithelia either directly (10, 16, 34, 37) or by inference from pharmacological effects (see below). Moreover, as might be expected for intratubular signaling, adenosine, ATP, and endothelin-1 are present in normal urine and have been shown to vary during certain pathological conditions (24, 32) . Their occurrence, particularly in the cases of adenosine and endothelin-1, are proposed to protect against ischemic damage by inhibiting the transport of Na ϩ (2, 6, 18). As briefly mentioned earlier, the amiloride-sensitive Na ϩ channel is inhibited by extracellular ATP, the level of which is partially determined by CFTR activity (15), thus allowing for cellular self-regulation of apical Na ϩ reabsorption. Additionally, apical application of adenosine in A6 cells, via a type A 2 receptor, produces an inhibition of Na ϩ channel activity (29) . Basolateral application of adenosine, on the other hand, produces an increase in Na ϩ transport (9) . Endothelin-1 applied basolaterally, most likely ET A receptor mediated, also produces a stimulation of apical Na ϩ channel activity (20) , thus suggesting a precedence that compounds, which may act through cPLA 2 , produce opposite effects when applied to the apical membrane vs. the basolateral membrane. Studies that determine the effects and dependence of apical agonists on cPLA 2 activity, free AA release at the apical membrane, and Na ϩ channel activity are currently under way.
On the basis of the data presented, we propose that 1) AA from cPLA 2 activity at or near the apical membrane is primarily responsible for downmodulation of transepithelial current, and 2) AA from cPLA 2 activity combined with cyclooxygenase activity within the cell, presumably perinuclear, produces PGE 2 , which is necessary to support transport. Together, the apical effect of AA downmodulation of ENaC and the necessity of the AA product PGE 2 to support transport provide a cellular signaling mechanism to fine-tune Na ϩ transport, based on the relative activity of cPLA 2 at the apical membrane and the perinuclear cPLA 2 and cyclooxygenase activity. With fixed cPLA 2 activity, manipulation of cyclooxygenase activity would result in relative changes of free AA. With greater cyclooxygenase activity, more PGE 2 would be produced, resulting in less free AA, which would tend to maximize transport. In contrast, less cyclooxygenase activity would yield less PGE 2 and result in more free AA, which would tend to minimize transport. Increased cPLA 2 activity at or near the apical membrane would tend to decrease transport, whereas increased cPLA 2 near an active cyclooxygenase enzyme would tend to increase transport. Indeed, as early as 1975, an increased phospholipid turnover was suggested to occur with stimulation of Na ϩ transport in toad bladder (22) . This increase was attributed to cellular increase in phospholipase activity (42) . This report provides further evidence as well as a model for the increased rate of phospholipid turnover and establishes the increased turnover as important in the regulation of Na ϩ transport. Specifically, AA and PGE 2 act in an antagonistic manner in A6 cells to modulate Na ϩ transport rate.
